Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism.
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Objective We evaluated the respective value of insulin, C-peptide and proinsulin levels in 33 patients with endogenous hyperinsulinism and in 67 controls to determine the best parameters and thresholds to make or to rule out the diagnosis of endogenous hyperinsulinism. Results When blood glucose levels were below 2.5 mmol/l, insulin was 0.2 nmol/l in all insulinomas but not in the nesidioblastosis or in the controls; proinsulin was >5 pmol/l in all patients but not in the controls. When fasting blood glucose levels reached 2.5-3.3 mmol/l, proinsulin was 22 pmol/l in 74% of the patients. Proinsulin after an overnight fast was below 22 pmol/l in all non-obese controls and above 22 pmol/l in 73% of non-obese patients. Conclusion Proinsulin levels above 5 pmol/l with blood glucose levels below 2.5 mmol/l during a 72 h fast test represent the best criterion for the diagnosis of endogenous hyperinsulinism, reaching 100% diagnostic specificity and sensitivity. Concomitant C-peptide levels above 0.2 nmol/l also make the diagnosis of all our insulinoma patients, not the diagnosis of nesidioblastosis, while insulin levels have much less diagnostic accuracy. Whether proinsulin levels above 22 pmol/l could also make the diagnosis of endogenous hyperinsulinism in part of the patients at the time of fasting blood glucose levels between 2.5 and 3.3 mmol/l or after an overnight fast in non-obese subjects needs further study.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, in one series the plasma insulin criterion was met in 29 of 32 patients with an insulinoma, whereas the C-peptide and proinsulin criteria were met in all 32 patients (61).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [61]
Citations
Cites
Forty-Eight-Hour Fast: The Diagnostic Test for Insulinoma
Hirshberg, B., Livi, A., Bartlett, D. L., Libutti, S. K., Alexander, H. R., Doppman, J. L., Skarulis, M. C., & Gorden, P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6807 · Cited by 256 · cited 10×
“In the past years, ratios calculated with insulin, blood glucose levels, then with proinsulin and insulin levels had been recommended (1, 3, 7 ). New assays leading to sensitive and specific evaluation of insulin, C-peptide and proinsulin are now in use and several thresholds were determined in order to make the diagn…”
BackgroundMethodInfluentialService, F. J., Natt, N., Thompson, G. B., Grant, C. S., van Heerden, J. A., Andrews, J. C., Lorenz, E., Terzic, A., & Lloyd, R. V. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5645 · Cited by 196
Automated kinetic method for D-3-hydroxybutyrate in plasma or serum
McMurray, C. H., Blanchflower, W. J., & Rice, D. A. (1984) · Clinical Chemistry · doi:10.1093/clinchem/30.3.421 · Cited by 188
Noninsulinoma pancreatogenous hypoglycemia syndrome: An update in 10 surgically treated patients
Thompson, G. B., Service, F. J., Andrews, J. C., Lloyd, R. V., Natt, N., van Heerden, J. A., & Grant, C. S. (2000) · Surgery · doi:10.1067/msy.2000.110243 · Cited by 121
Homeostasis During Fasting. II. Hormone Substrate Differences Between Men and Women
MERIMEE, T. J., & FINEBERG, S. E. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-5-698 · Cited by 82 · cited 1×
“First, we confirm that healthy subjects can have blood glucose levels below 3.3 mmol/l or even below 2.5 mmol/l during the fast test (1, 22 ), the lowest level being above 2 mmol/l (2.3 mmol/l) in our study.”
BackgroundInfluentialProinsulin by immunochemiluminometric assay for the diagnosis of insulinoma
Kao, P. C. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1048 · Cited by 65 · cited 2×
“When blood glucose levels are between 2.5 and 3.3 mmol/l during the fast test, insulin and C-peptide levels overlapped between controls and patients ( 9 ).”
BackgroundInfluentialInvestigation of hypoglycaemia
Marks, V., & Teale, J. D. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.659478.x · Cited by 51 · cited 2×
“Then, a 6 mIU/l (43 pmol/l) insulin threshold and a 0.6 ng/ml (0.2 nmol/l) C-peptide threshold concomitant with symptomatic hypoglycaemia below 0.45 g/l (2.5 mmol/l) was established by Service et al. (1), while others recommended cut-off values of 5 mIU/l (36 pmol/l) and 0.9 ng/ml (0.3 nmol/l) at the time of hypoglyca…”
BackgroundMethodInfluentialVezzosi, D., Bennet, A., Fauvel, J., Boulanger, C., Tazi, O., Jp, L., & Caron, P. J. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490413 · Cited by 49 · cited 1×
“In the present study, we confirm our previous finding that at the time of hypoglycaemia below 2.5 mmol/l, several patients (11–35%) with endogenous hyperinsulinism have insulin levels below 21 pmol/l ( 4 ).”
ResultInfluentialSelf-citationInsulin surrogates in insulinoma
O'Brien, T. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.2.448 · Cited by 47 · cited 1×
“Hypoglycaemia related to endogenous hyperinsulinism was excluded if, during the 72-h fast test, blood glucose did not decrease below 3.3 mmol/l or if serum b-hydroxybutyrate concentrations reached 2700 mmol/l with concomitant blood glucose between 2.5 and 3.3 mmol/l (10, 11 ).”
BackgroundInfluentialStarke, A., Saddig, C., Kirch, B., Tschahargane, C., & Goretzki, P. (2006) · World Journal of Surgery · doi:10.1007/s00268-005-0543-6 · Cited by 46 · cited 2×
“Moreover, it has been shown that patients with nesidioblastosis and even some rare glucose-sensitive insulinoma patients can undergo a 72-h fast test without hypoglycaemia ( 15 ) ,s uch patients being detected only with an oral glucose tolerance test (OGTT) or a meal test.”
Background
Cited by
Items 101–152 of 152
Lea, R. A. W. (2016) · doi:10.1002/9781118634943.ch8 · Cited by 2
(2023) · Advances in Bioengineering and Biomedical Science Research · doi:10.33140/abbsr.06.03.003 · Cited by 2
Oleinikov, K., Gross, D. J., Jacob, H., Mazeh, H., & Grozinsky‐Glasberg, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-56968-5_12 · Cited by 3
Popa, S. G., Golli, A. L., Matei, C., Sonei, A. N., Vere, C. C., Cîmpeanu, R.-C., Munteanu, M., & Munteanu, A. C. (2025) · Diagnostics · doi:10.3390/diagnostics15030337 · Cited by 2
“In this context, the urgent initiation of the clinical, biological and imaging evaluation of the patient is required in order to establish the etiological diagnosis and the optimal therapy to avoid the serious consequences of severe hypoglycemia [7,8].”
Lu, C., Hua, S., & Wu, C.-J. (2008) · 內科學誌 · doi:10.6314/jimt.2008.19(5).09 · Cited by 1
Tura, A., Hecking, M., Wolzt, M., Säemann, M. D., & Pacini, G. (2015) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2015.7318870 · Cited by 2
Pancreatic Neuroendocrine Tumours
Chew, C. A. Z., & Bonney, G. K. (2018) · Springer eBooks · doi:10.1007/978-981-10-1124-5_36 · Cited by 1
Schäffler, A., Bollheimer, C., Büttner, R., Girlich, C., Aslanidis, C., Dietmaier, W., Bala, M., Guralnik, V., Karrasch, T., & Schneider, S. (2018) · Springer eBooks · doi:10.1007/978-3-662-55914-7_2 · Cited by 1
Peptide C : un coproduit de la biosynthèse de l’insuline ou une hormone peptidique active ?
Mavrakanas, T. A., & Bastide, D. (2008) · La Presse Médicale · doi:10.1016/j.lpm.2008.07.015 · Cited by 1
“[35] Vezzosi D, Bennet A, Fauvel J, Caron P.”
BackgroundHiperinsulinismo endógeno: dois desafios diagnósticos
Gonçalves, A. P., Baptista, F., Nobre, E. L., & do Carmo, I. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000002368 · Cited by 1
“Em ambos os casos, os anticorpos apresentam elevada capacidade e baixa afinidade (2,13).”
BackgroundCryer, P. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00034-4 · Cited by 5
Morte por envenenamento através da administração da insulina: uma revisão
Biancalana, M. M., & Zerbini, T. (2011) · Saúde Ética & Justiça · doi:10.11606/issn.2317-2770.v16i1p18-29 · Cited by 1
An elderly woman with recurrent episodes of confusion
Brooks, A. M., & Vaidya, B. (2010) · BMJ · doi:10.1136/bmj.c1998 · Cited by 1
“A 72 hour fast causes hypoglycaemia in 99% of patients with insulinomas.”
BackgroundExploring the structure, function & regulation of the human glucagon-like peptide-1 receptor
Huang, Y. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 2
Presentación atípica de insulinoma
García, G. L., Ferrer-García, J. C., Montoro-Botella, A., & Sánchez-Juan, C. (2013) · Revista Médica Herediana · doi:10.20453/rmh.v24i3.326
Stoornissen van het glucosemetabolisme – forensische postmortemanalyses: deel I
Hess, C., Mußhoff, F., & Madea, B. (2014) · Nederlands Tijdschrift voor Diabetologie · doi:10.1007/s12467-014-0006-5
Falsely diminished results for insulin concentrations measured with the IMMULITE® 2000
Silla, E. C., Rosel, P., Solé-Enrech, G., Alia, P. J., & Padró‐Miquel, A. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.051
Les proinsulines : caractéristiques immunoanalytiques
Chevenne, D. (2012) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/j.immbio.2012.01.007
Insulinoma, a propósito de dos casos
González, J. L. G., Villalonga, J. A. G., González, D. P., Núñez, J. M., & Lazo, A. A. (n.d.) · DOAJ (DOAJ: Directory of Open Access Journals)
Neuroendocrine tumors - insulinoma in clinical practise
Gierach, M., Gierach, J., Skowrońska, A., & Junik, R. (2013) · Postępy Nauk Medycznych
Insulinoma. Diagnostic criteria and treatment Insulinoma. Criterios diagnósticos y tratamiento
Felechosa, M. D., & Fernández, M. R. (2009)
Neuroendocrine Tumors of the Pancreas
Carolan, P. J., & Chung, D. C. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch88
Biancalana, M. M., & Zerbini, T. (2011)
Case 33-2012: A Woman with Altered Mental Status after Childbirth
Lehmann, L. S. (2013)
Gonçalves, A. P., Baptista, F., & Nobre, E. L. (2014)
Vezzosi, D., Bennet, A., Grunenwald, S., & Caron, P. J. (2016) · La Presse Médicale · doi:10.1016/j.lpm.2016.04.009
Self-citationA Case of Insulinoma With Provoked Seizures for the Past Fourteen Years: A Case Report
kadkhodazadeh, H., Kazempour, M., & Salevatipour, B. (2015) · Archives of Critical Care Medicine · doi:10.17795/accm-7511
“0 pmol/L or higher in such patients (3).”
BackgroundUeda, K., Lee, L., & Ito, T. (2018) · Wiley eBooks · doi:10.1002/9781119188421.ch133 · Cited by 1
Enucleation of Pancreatic Proinsulinoma: Case Report
Pires, G. A. (2016) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2016.03.00062
Pršo, M., Szökeová, A., Havlíčeková, Z., Michnová, Z., Raffajová, D., Jancinová, M., Bánovčin, P., Bánovčin, P., Uhrík, P., & Hyrdel, R. (2018) · Pediatrie pro praxi · doi:10.36290/ped.2018.023
“Koncentrácia proinzulínu je často zvýšená a v kombinácii s hypoglykémiou je vysoko suspektná z prítomnosti inzulinómu (8).”
Hypoglycémie : le crime parfait ? Le point de vue du légiste
Ludes, B. (2011) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(11)70274-7 · Cited by 1
Hypoglycemia After Gastric Bypass
Alvarez, G. D. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-28803-7_35
Pediatric Diabetes: Review Article
Bavishna, B., Devi, R. U., & Krishnan, S. G. (2019) · Indian Journal of Public Health Research & Development · doi:10.5958/0976-5506.2019.04013.0
Stoornissen van het glucosemetabolisme – forensische postmortemanalyses: deel II
Mußhoff, F., Hess, C., & Madea, B. (2014) · Nederlands Tijdschrift voor Diabetologie · doi:10.1007/s12467-014-0007-4
(2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32830c6b8e
Grozinsky‐Glasberg, S., Reissman, P., & Gross, D. J. (2015) · Springer eBooks · doi:10.1007/978-3-662-45215-8_12
Presentación atípica de insulinoma
García, G. L., Ferrer-García, J. C., Montoro-Botella, A., & Sánchez-Juan, C. (2013) · Revista Médica Herediana · doi:10.20453/rnp.2013.326
Schäffler, A., Bollheimer, C., Büttner, R., Girlich, C., Aslanidis, C., Dietmaier, W., Bala, M., Guralnik, V., Karrasch, T., & Wurm, S. (2012) · Springer eBooks · doi:10.1007/978-3-642-29690-1_2
Presentación atípica de insulinoma
García, G. L., Ferrer-García, J. C., Montoro-Botella, A., & Sánchez-Juan, C. (2013) · Revista Médica Herediana · doi:10.20453/rmh.2013.326
Schäffler, A., Bollheimer, C., Büttner, R., Girlich, C., Aslanidis, C., Dietmaier, W., Bala, M., Guralnik, V., Karrasch, T., & Schneider, S. (2015) · Springer eBooks · doi:10.1007/978-3-662-47480-8_2
Ueda, K., Fujimori, N., Jensen, R. T., & Ito, T. (2023) · Wiley eBooks · doi:10.1002/9781119876007.ch112
Diagnostic pitfall in hypoglycemia: Insulinoma in tail of pancreas
Sikka, A., Modanwal, P., & Kapila, H. (2023) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2023.19.2.1150
Enucleation of a solitary pancreatic tail insulinoma: a case report and review of the literature
Gomez, D. M., & Subasinghe, D. (2024) · MedNEXT Journal of Medical and Health Sciences · doi:10.54448/mdnt24202 · Cited by 1
Schäffler, A., & Karrasch, T. (2024) · Springer eBooks · doi:10.1007/978-3-662-68563-1_2
Insulinoma: Unraveling the Mystery of a Stealthy Culprit
Mahaldar, E. A., Khan, K., Khan, M., & Shahbuddin, M. I. (2024) · Cureus · doi:10.7759/cureus.74364 · Cited by 1
“Persistent hypoglycemia is caused by this increased insulin secretion, especially when fasting or exercising when glucose availability is restricted [4].”
Spontaneous hypoglycemia: A narrative review
Rahman, M. A., Islam, M. H., Khan, M. A., & Fariduddin, M. (2024) · Journal of Association of Clinical Endocrinologist and Diabetologist of Bangladesh · doi:10.3329/jacedb.v3i2.78644
“21 So, if endpoints are not met even after 72 hours fast, the Glucagon challenge test can provide additional clues for the diagnosis of endogenous insulin/IGF-mediated hypoglycemia.”
Huda, F. N., Hutajulu, S. H., Aresy, S., Pramono, R. B., Barmawi, A., Sumpono, A. S. B., & Setyawan, N. H. (2025) · Cureus · doi:10.7759/cureus.77662
Pancreatic Neuroendocrine Tumors
Kim, M. K., Yang, J. T., Farha, N., & Goldman, I. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-11760-2.00085-9
Strużek, K., Kwiatkowska, A., Mączka, E., Tracz, W., Świercz, P., Teper, K., Khiralla-Gawlik, S., Strzelecka, A. A., & Basak, A. E. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3659
“[43 ] The introduction of proinsulin testing has allowed serum proinsulin thresholds to be used as a diagnostic tool.”
Zaihan, A. F., Hisham, S. A., Siwalinggam, S., Noralam, N. H. A. A., Thiruchelvam, K., & Kow, C. S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1859250
Diagnosis and ongoing evaluation
Bruggeman, B. S., Jacobsen, L. M., Foster, T. P., & Winter, W. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-21725-8.00015-9
Yu, M., Ji, X., & Zheng, P. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1802157
Metadata
- Authors
- Vezzosi, D., Bennet, A., Fauvel, J., & Caron, P.
- Affiliations
- Hôpital Rangueil (FR)
- Corresponding author
- Caron, P
- ORCID
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-07
- Volume
- 157
- Issue
- 1
- Pages
- 75-83
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2110510376
- Cited by
- 152
- References
- 19
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 10 · 2023: 9 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 6 · 2018: 6 · 2017: 9 · 2016: 10 · 2015: 13 · 2014: 10 · 2013: 16 · 2012: 10
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- endogenous hyperinsulinism, hypoglycemia, insulinoma, proinsulin, C-peptide, insulin, biochemical diagnosis, nesidioblastosis, fasting blood glucose, diagnostic thresholds
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Blood Glucose, C-Peptide, Circadian Rhythm, Diagnostic Techniques, Endocrine, Fasting, Female, Humans, Hyperinsulinism, Hypoglycemia, Insulin, Male, Middle Aged, Proinsulin, Sensitivity and Specificity, Time Factors, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.